Iofina (IOF) Competitors GBX 24.34 +0.09 (+0.35%) As of 07/3/2025 11:37 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock IOF vs. SYNT, ZTF, TET, DCTA, HAYD, WCH, ITX, HDD, BIOM, and VRSShould you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Synthomer (SYNT), Zotefoams (ZTF), Treatt (TET), Directa Plus (DCTA), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Hardide (HDD), Biome Technologies (BIOM), and Versarien (VRS). These companies are all part of the "specialty chemicals" industry. Iofina vs. Its Competitors Synthomer Zotefoams Treatt Directa Plus Haydale Graphene Industries Wilmcote Holdings plc (WCH.L) Itaconix Hardide Biome Technologies Versarien Iofina (LON:IOF) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation. Is IOF or SYNT more profitable? Iofina has a net margin of 6.98% compared to Synthomer's net margin of -4.40%. Iofina's return on equity of 8.00% beat Synthomer's return on equity.Company Net Margins Return on Equity Return on Assets Iofina6.98% 8.00% 5.18% Synthomer -4.40%-7.52%-0.28% Which has more risk and volatility, IOF or SYNT? Iofina has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Which has stronger earnings & valuation, IOF or SYNT? Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIofina£61.34M0.95£4.28M£1.4217.08Synthomer£1.87B0.09-£82.04M-£49.90-1.94 Do insiders & institutionals believe in IOF or SYNT? 6.4% of Iofina shares are owned by institutional investors. Comparatively, 43.8% of Synthomer shares are owned by institutional investors. 45.1% of Iofina shares are owned by company insiders. Comparatively, 28.0% of Synthomer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate IOF or SYNT? Iofina presently has a consensus price target of GBX 36.25, indicating a potential upside of 48.96%. Synthomer has a consensus price target of GBX 225, indicating a potential upside of 132.20%. Given Synthomer's higher probable upside, analysts plainly believe Synthomer is more favorable than Iofina.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iofina 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Synthomer 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media favor IOF or SYNT? In the previous week, Synthomer had 7 more articles in the media than Iofina. MarketBeat recorded 7 mentions for Synthomer and 0 mentions for Iofina. Synthomer's average media sentiment score of 0.26 beat Iofina's score of 0.00 indicating that Synthomer is being referred to more favorably in the news media. Company Overall Sentiment Iofina Neutral Synthomer Neutral SummaryIofina beats Synthomer on 10 of the 16 factors compared between the two stocks. Get Iofina News Delivered to You Automatically Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IOF vs. The Competition Export to ExcelMetricIofinaSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£58.43M£8.18B£3.27B£2.96BDividend Yield2.88%3.52%5.14%5.02%P/E Ratio17.0813.4693.52146.59Price / Sales0.9559.2427,136,382,376,958,800.00240,167.53Price / Cash7.9619.2523.8627.97Price / Book1.084.605.895.30Net Income£4.28M£220.83M£147.76M£5.90B7 Day Performance-0.63%1.00%2.27%0.92%1 Month Performance-2.66%6.44%5.60%5.20%1 Year Performance33.06%-8.05%25.49%80.76% Iofina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IOFIofinaN/AGBX 24.34+0.4%GBX 36.25+49.0%+35.2%£58.43M£61.34M17.0895Gap UpSYNTSynthomer3.2834 of 5 starsGBX 105.20-0.6%GBX 225+113.9%-66.4%£172.50M£1.87B-2.114,200News CoverageInsider TradeZTFZotefoamsN/AGBX 321+1.3%N/A-31.9%£154.39M£131.66M15.54549Gap DownTETTreatt2.8272 of 5 starsGBX 250+0.2%GBX 650+160.0%-42.6%£151.15M£142.31M13.51350Positive NewsDividend IncreaseGap UpDCTADirecta PlusN/AGBX 16.50-1.5%N/A-32.8%£22.20M£20.29M-2.94187HAYDHaydale Graphene IndustriesN/AGBX 0.56-16.4%N/A+122.4%£20.90M£14.20M-1.1667Gap DownWCHWilmcote Holdings plc (WCH.L)N/AN/AN/AN/A£20.13MN/A-5.003ITXItaconixN/AGBX 110+4.8%N/A-16.5%£14.84M£5.28M-9.9617Gap UpHDDHardideN/AGBX 8.48+2.7%N/A+7.1%£6.68M£6.11M-3.5446BIOMBiome TechnologiesN/AGBX 6.95-0.3%N/A-89.6%£3.58M£78.36M-0.2027VRSVersarienN/AGBX 0.04flatN/A-80.7%£862K£5.32M-0.9370Earnings ReportGap DownHigh Trading Volume Related Companies and Tools Related Companies SYNT Competitors ZTF Competitors TET Competitors DCTA Competitors HAYD Competitors WCH Competitors ITX Competitors HDD Competitors BIOM Competitors VRS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IOF) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iofina plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Iofina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
